4
Changes in Ownership
Trevi Therapeutics, Inc. Filed Acc 0000950170-24-101926
Director sold 4,555 shares at $2.93 ($13,353)
- Director acquired 4,555 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Meeker David P · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-27 | Exercise or conversion : show line 1 in the form | +4,555 | $1.43 | $6,514 | 357,044 | D |
| 2024-08-27 | Sale : show line 2 in the form | −4,555 | $2.93 | $13,353 | 352,489 | D |
| Open-market sales · 4,555 sh · avg $2.93 · $13,353 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-08-27 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −4,555 | 0 | D |
Loading xslF345X05/ownership.xml…